收藏切换
Recent drug research progress on antioxidant for chronic obstructive pulmonary disease
收藏切换
Yujie SUN1, 2, Fenghua GU1, 2, *
World Clinical Drug | 2022, 43(12) : 1641 - 1644
Less
收藏切换
World Clinical Drug | 2022, 43(12): 1641-1644
• Review •
Recent drug research progress on antioxidant for chronic obstructive pulmonary disease
Full
Yujie SUN1, 2, Fenghua GU1, 2, *
Affiliations
  • 1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
  • 2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China
Published: 2022-12-10 doi: 10.13683/j.wph.2022.12.021
Outline
收藏切换

Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by persistent respiratory symptoms and airflow restriction, caused by airway and/or alveolar abnormalities resulting from significant exposure to harmful particulate matter or gases. Difficulty breathing, cough and/or phlegm are the most common symptoms of COPD. The incidence and mortality of COPD are increasing year by year and is the fourth leading cause of death worldwide. Reactive oxygen species produced by cigarette smoke can damage lung structure and function, causing pulmonary oxidative stress disorder and COPD. Oxidative stress is the key to the pathogenesis of COPD. Traditional COPD drugs have limited ability to control oxidative stress, and clinical evidence of antioxidant stress is insufficient. Thioredoxin and N-acetyl-L-cysteine as molecules of the body's own antioxidant defense system have become research hotspots. This paper reviewed the pathogenesis of oxidative stress and research hotspot of antioxidants of COPD to provide reference for clinical practice.

chronic obstructive pulmonary disease  /  antioxidant  /  drug research
孙玉杰, 顾丰华. 慢性阻塞性肺疾病抗氧化剂最新药物研究进展. 世界临床药物, 2022 , 43 (12) : 1641 -1644 . DOI: 10.13683/j.wph.2022.12.021
Yujie SUN, Fenghua GU. Recent drug research progress on antioxidant for chronic obstructive pulmonary disease[J]. World Clinical Drug, 2022 , 43 (12) : 1641 -1644 . DOI: 10.13683/j.wph.2022.12.021
Year 2022 volume 43 Issue 12
12
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.12.021
  • Receive Date:2022-05-30
  • Online Date:2026-11-18
  • Published:2022-12-10
Article Data
Affiliations
History
  • Received:2022-05-30
Affiliations
    1.State Key Laboratory of & New Drug Pharmaceutical Process, China State Institute of Pharmaceutical Industry, Shanghai 200437, China
    2.Shanghai Technical Service Platform for Biological Material Druggability Evaluation, Shanghai 200437, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.12.021
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT